Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ATRION Corp. (NASDAQ: ATRI).

Full DD Report for ATRI

You must become a subscriber to view this report.


Recent News from (NASDAQ: ATRI)

Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals - Discovering Underlying Factors of Influence
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atrion Corporation (NASDAQ:ATRI), Curis, Inc. (NASDAQ:CRIS), Independenc...
Source: GlobeNewswire
Date: April, 03 2018 08:00
Atrion Corporation 2017 Year In Review
Business Overview Atrion Corporation ( ATRI ) develops and manufactures products, primarily for medical applications. The company markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other tr...
Source: SeekingAlpha
Date: March, 14 2018 11:06
Free Post Earnings Research Report: Mettler-Toledo's Quarterly Earnings Increased 13.07%
Stock Monitor: Atrion Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 12, 2018 / Active-Investors.com has just released a free earnings report on Mettler-Toledo International Inc. (NYSE: MTD ) ("MTD").If you want access to this report all you need to do is sign up now by cli...
Source: ACCESSWIRE IA
Date: March, 12 2018 07:00
Upcoming Dividends: 83 Companies, 35 Increases, 17 Double-Digit Increases
Introduction The information presented below was created based on combining the "U.S. Dividend Champion" spreadsheet compiled by David Fish hosted here with upcoming dividend information from the Nasdaq . This meshes metrics about companies with dividend growth history with upcoming divid...
Source: SeekingAlpha
Date: March, 08 2018 12:52
Atrion Reports 2017 Results for Fourth Quarter and Full Year
ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) announced today that for the fourth quarter of 2017 revenues were $34.0 million compared to $33.3 million in the same period of 2016, net income was $8.6 million compared to $5.6 million, and diluted earnings p...
Source: GlobeNewswire
Date: February, 27 2018 16:30
Atrion Corporation declares $1.20 dividend
Atrion Corporation (NASDAQ: ATRI ) declares $1.20/share quarterly dividend , in line with previous. More news on: Atrion Corporation, Dividend news, Read more ...
Source: SeekingAlpha
Date: February, 27 2018 14:58
Market Trends Toward New Normal in Alexander's, Atrion, FS, Gilead Sciences, Abbott Laboratories, and Johnson & Johnson - Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alexander's, Inc. (NYSE:ALX), Atrion Corporation (NASDAQ:ATRI), FS Bancor...
Source: GlobeNewswire
Date: February, 01 2018 08:00
The 1% Dividend Growth Model Portfolio Will Break The Mold And Transform Opinions
When it comes to low yielding dividend growth stocks, many dividend growth investors tend to ignore them because their yield does not allow them to accumulate much in the way of dividends in the short term. But what about long term? For new or young investors with a long investment time horizo...
Source: SeekingAlpha
Date: January, 18 2018 11:04
102 Dividend Growth Stocks Going Ex-Dividend Next Week
Introduction The information presented below was created based on combining the "U.S. Dividend Champion" spreadsheet compiled by David Fish hosted here with upcoming dividend information from the Nasdaq . This meshes metrics about companies with dividend growth history with upcoming divid...
Source: SeekingAlpha
Date: November, 22 2017 16:08
Your Daily Pharma Scoop: Valeant Remains Risky, Novartis's Kisqali, Tesaro Tumbles
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Valeant Today we will disc...
Source: SeekingAlpha
Date: November, 09 2017 08:23

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-17610.00596.85610.00589.503,021
2017-02-02479.75466.20486.05466.203,885
2017-02-01493.85480.70493.85480.005,052
2017-01-31489.90488.60494.05488.604,227
2017-01-30505.00496.20505.00496.204,151

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2123123598.2979Short
2018-08-205926622.1805Cover
2018-08-1717529359.7270Short
2018-08-1684493090.7527Short
2018-08-1515325659.7656Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ATRI.


About ATRION Corp. (NASDAQ: ATRI)

Logo for ATRION Corp. (NASDAQ: ATRI)

Not available

 

Contact Information

 

 

Current Management

  • Emile A. Battat / CEO
  • Jeffery Strickland / CFO

Current Share Structure

  • Market Cap: $1,083,790,531 - 05/14/2018
  • Issue and Outstanding: 1,851,842 - 07/20/2017

 


Recent Filings from (NASDAQ: ATRI)

Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 09 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 23 2018

 

 


Daily Technical Chart for (NASDAQ: ATRI)

Daily Technical Chart for (NASDAQ: ATRI)


Stay tuned for daily updates and more on (NASDAQ: ATRI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ATRI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ATRI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ATRI and does not buy, sell, or trade any shares of ATRI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/